Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.

If confirmed as the HHS Secretary by the US Senate, RFK Jr will oversee federal agencies that dictate healthcare policy in ...

Zoomcar Holdings, Inc.  ('Zoomcar,' or 'we,' or 'our'), the leading marketplace for car sharing in India, today announced results for its second quarter ended September 30, 2024. Hiroshi Nishijima, ...

By using automated content recognition, Beatgrid can measure cross-platfrom ad exposure by individual as well as the ...

For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...

MINNEAPOLIS, MN, US, Nov. 14, 2024 (GLOBE NEWSWIRE) -- (OTCQB: PETV, PETVW), a leading biomedical company delivering ...

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: ...

Baidu CEO’s life sciences startup sees artificial intelligence as the inevitable force driving transformation in drug ...

Bluebird bio Inc., which nine years ago was worth nearly as much as the airline JetBlue, said it's now looking for enough ...

Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient ...

With President-elect Donald Trump returning to the White House, a changing of the guard at the Federal Trade Commission (FTC) ...

Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study of uliledlimab ...